529
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

, , &
Pages 1515-1522 | Published online: 22 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Laia Montoliu-Gaya, Javier Murciano-Calles, Jose C. Martinez & Sandra Villegas. (2017) Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential. Amyloid 24:3, pages 167-175.
Read now
Thomas Müller & Paul Foley. (2016) Clinical drug research in chronic central neurodegenerative disorders. Expert Review of Neurotherapeutics 16:5, pages 497-504.
Read now
Francesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, Rosanna Tortelli, Andrea Santamato & Giancarlo Logroscino. (2014) Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. Expert Review of Clinical Immunology 10:3, pages 405-419.
Read now
Zhihua Qiu & Yimin Dai. (2014) Roadmap of miR-122-related clinical application from bench to bedside. Expert Opinion on Investigational Drugs 23:3, pages 347-355.
Read now

Articles from other publishers (15)

Caterina Vicidomini, Nicola Borbone, Valentina Roviello, Giovanni N. Roviello & Giorgia Oliviero. (2023) Summary of the Current Status of DNA Vaccination for Alzheimer Disease. Vaccines 11:11, pages 1706.
Crossref
D. G. Garbuz, O. G. Zatsepina & M. B. Evgen’ev. (2021) Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis. Molecular Biology 55:5, pages 670-682.
Crossref
Wen-Hui Ma, Ai-Fang Chen, Xiao-Yang Xie & Yun-Sheng Huang. (2021) Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease. Neuropharmacology 190, pages 108342.
Crossref
Thomas Müller. 2020. Diagnosis and Management in Dementia. Diagnosis and Management in Dementia 547 558 .
Hyunjung Baek, Chan-ju Lee, Da Bin Choi, Nam-sik Kim, Yong-Suk Kim, Young Jun Ye, Youn-Sub Kim, Jin Su Kim, Insop Shim & Hyunsu Bae. (2018) Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model. Scientific Reports 8:1.
Crossref
M. Dieterich & A. Zwergal. (2018) Interdisziplinäre Herausforderungen in der NeuromedizinInterdisciplinary challenges in neuromedicine. Der Nervenarzt 89:10, pages 1081-1082.
Crossref
Barbara Mroczko, Magdalena Groblewska, Ala Litman-Zawadzka, Johannes Kornhuber & Piotr Lewczuk. (2017) Amyloid β oligomers (AβOs) in Alzheimer’s disease. Journal of Neural Transmission 125:2, pages 177-191.
Crossref
Bahareh Eftekharzadeh, Bradley T. Hyman & Susanne Wegmann. (2016) Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases. Mechanisms of Ageing and Development 156, pages 1-13.
Crossref
Laia Montoliu-Gaya & Sandra Villegas. (2016) A β -Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment . Expert Reviews in Molecular Medicine 18.
Crossref
Jack Losso. 2015. The Maillard Reaction Reconsidered. The Maillard Reaction Reconsidered 283 312 .
Marta Westwood & Alastair Lawson. (2015) Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases. Antibodies 4:3, pages 170-196.
Crossref
Douglas G. Walker, Alexis M. Whetzel, Geidy Serrano, Lucia I. Sue, Thomas G. Beach & Lih-Fen Lue. (2015) Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex. Neurobiology of Aging 36:2, pages 571-582.
Crossref
M. S. Kukharsky, R. K. Ovchinnikov & S. O. Bachurin. (2015) Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer?s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:6, pages 103.
Crossref
Hyun Yang & Dong Seok Kim. 2015. Peptide and Protein Vaccines. Peptide and Protein Vaccines 1 14 .
Hui Jin, Weixi Wang, Shanshan Zhao, Weina Yang, Yihua Qian, Ning Jia & Gaifeng Feng. (2014) Aβ-HBc virus-like particles immunization without additional adjuvant ameliorates the learning and memory and reduces Aβ deposit in PDAPP mice. Vaccine 32:35, pages 4450-4456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.